165 related articles for article (PubMed ID: 28971213)
21. Cyclosporine for the treatment of granulocytopenia in Felty's syndrome.
Canvin JM; Dalal BI; Baragar F; Johnston JB
Am J Hematol; 1991 Mar; 36(3):219-20. PubMed ID: 1996561
[TBL] [Abstract][Full Text] [Related]
22. [Inflammatory rheumatism and fundamentals of its drug therapy].
Borkenstein E
Wien Med Wochenschr; 1971 May; 121(22):449-52. PubMed ID: 5314609
[No Abstract] [Full Text] [Related]
23. [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs; 3. Cyclophosphamide for systemic rheumatic diseases].
Kameda H
Nihon Naika Gakkai Zasshi; 2011 Oct; 100(10):2918-23. PubMed ID: 22175131
[No Abstract] [Full Text] [Related]
24. [Assessment of pharmacological correction in the treatment of patients with systemic lupus erythematosus].
Sultanova TZh
Lik Sprava; 2009; (7-8):86-9. PubMed ID: 20455456
[TBL] [Abstract][Full Text] [Related]
25. Successful treatment of chronic inflammatory demyelinating polyneuropathy (CIDP) in systemic lupus erythematosus (SLE) with oral cyclophosphamide.
Jasmin R; Sockalingam S; Shahrizaila N; Cheah TE; Zain AA; Goh KJ
Lupus; 2012 Sep; 21(10):1119-23. PubMed ID: 22433918
[TBL] [Abstract][Full Text] [Related]
26. The Safety of Intravenous Cyclophosphamide in the Treatment of Rheumatic Diseases.
Woytala PJ; Morgiel E; Łuczak A; Czesak-Woytala K; Wiland P
Adv Clin Exp Med; 2016; 25(3):479-84. PubMed ID: 27629736
[TBL] [Abstract][Full Text] [Related]
27. [Indications--intravenous immunoglobulins--IVIG].
Etzioni A; Sherer Y; Carp H; Mimouni D; Achiron A; Goddard G; Catz U; Shoenfeld Y
Harefuah; 2005 Nov; 144(11):799-804. PubMed ID: 16358657
[No Abstract] [Full Text] [Related]
28. [Pulmonary hemorrhage in patients with systemic lupus erythematosus. Clinical manifestations and prognosis].
Finucci Curi P; Pierrestegui M; Ortiz A; Ceccato F; Paira S
Med Clin (Barc); 2015 Nov; 145(9):375-9. PubMed ID: 25458514
[TBL] [Abstract][Full Text] [Related]
29. A case of systemic lupus erythematosus presenting with protein-losing enteropathy.
Türkçapar N; Ozyüncü N; Cinar K; Ensari A; Küçük O; Idilman R; Duman N; Ozden A
Turk J Gastroenterol; 2006 Sep; 17(3):226-30. PubMed ID: 16941261
[TBL] [Abstract][Full Text] [Related]
30. Immunosuppressive drug therapy of systemic lupus erythematosus.
Fox DA; McCune WJ
Rheum Dis Clin North Am; 1994 Feb; 20(1):265-99. PubMed ID: 8153402
[TBL] [Abstract][Full Text] [Related]
31. The complement system as a potential therapeutic target in rheumatic disease.
Trouw LA; Pickering MC; Blom AM
Nat Rev Rheumatol; 2017 Sep; 13(9):538-547. PubMed ID: 28794515
[TBL] [Abstract][Full Text] [Related]
32. [Human parvovirus B19 infection mimicking systemic lupus erythematosus: case report].
Banno S; Matsumoto Y; Sugiura Y; Ueda R
Ryumachi; 1997 Aug; 37(4):581-6. PubMed ID: 9311285
[TBL] [Abstract][Full Text] [Related]
33. Practical use of immunosuppressive drugs in autoimmune rheumatic diseases.
De Jesus A; Talal N
Crit Care Med; 1990 Feb; 18(2 Suppl):S132-7. PubMed ID: 2298028
[TBL] [Abstract][Full Text] [Related]
34. Recurrent spontaneous subdural hematoma secondary to immune thrombocytopenia in a patient with overlap syndrome.
Goh KG; Ong SG
Lupus; 2015 Jan; 24(1):90-3. PubMed ID: 25305213
[TBL] [Abstract][Full Text] [Related]
35. Cyclophosphamide versus methylprednisolone for treating neuropsychiatric involvement in systemic lupus erythematosus.
Trevisani VF; Castro AA; Neves Neto JF; Atallah AN
Cochrane Database Syst Rev; 2006 Apr; (2):CD002265. PubMed ID: 16625558
[TBL] [Abstract][Full Text] [Related]
36. Thrombotic thrombocytopenic purpura and systemic lupus erythematosus: a rare and life-threatening association.
El Khayat SS; Medkouri G; Etomba AM; Zamd M; Gharbi MB; Ramadani B
Arab J Nephrol Transplant; 2012 May; 5(2):103-5. PubMed ID: 22612197
[TBL] [Abstract][Full Text] [Related]
37. Disease flare patterns and predictors of systemic lupus erythematosus in a monocentric cohort of 423 Japanese patients during a long-term follow-up: The JUDE study.
Minowa K; Amano H; Ando S; Watanabe T; Ogasawara M; Kawano S; Kaneko T; Morimoto S; Yamaji K; Tamura N; Tokano Y; Hashimoto H; Takasaki Y
Mod Rheumatol; 2017 Jan; 27(1):72-76. PubMed ID: 27539069
[TBL] [Abstract][Full Text] [Related]
38. Systemic lupus erythematosus-associated acute transverse myelitis: manifestations, treatments, outcomes, and prognostic factors in 20 patients.
Saison J; Costedoat-Chalumeau N; Maucort-Boulch D; Iwaz J; Marignier R; Cacoub P; Vital-Durand D; Hot A; Tebib J; Aumaitre O; Schleinitz N; Sarrot-Reynauld F; Broussolle C; Sève P
Lupus; 2015 Jan; 24(1):74-81. PubMed ID: 25117654
[TBL] [Abstract][Full Text] [Related]
39. Systemic lupus erythematosus in Thai children: clinicopathologic findings and outcome in 82 patients.
Pattaragarn A; Sumboonnanonda A; Parichatikanond P; Supavekin S; Suntornpoch V; Vongjirad A
J Med Assoc Thai; 2005 Nov; 88 Suppl 8():S232-41. PubMed ID: 16856445
[TBL] [Abstract][Full Text] [Related]
40. Autoimmune myelofibrosis with pancytopenia as a presenting manifestation of systemic lupus erythematosus responsive to mycophenolate mofetil.
Ungprasert P; Chowdhary VR; Davis MD; Makol A
Lupus; 2016 Apr; 25(4):427-30. PubMed ID: 26537421
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
